Transparency Market Research in its new report titled, “Cholera Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the cholera vaccines market. The new report anticipates that the increasing prevalence of cholera in developing regions will drive the cholera vaccines market during the forecast period i.e, 2018-2026.

Cholera control is supposed to be a number one priority at the rise of a cholera epidemic in a report published by WHO. Presently, there are two types of oral cholera vaccines accessible in the market. These oral vaccines should be used in conjunction with other preventive measures in areas where the disease is endemic.

Vaccination provides an immediate short-term response. However, to make sure that the disease doesn’t affect the patient later on, other interventions such as availability of clean water and proper sanitation should be put into place. The WHO strongly recommends monitoring for confirmed cases of cholera disease must be integrated in existing surveillance programs so that the impact of the disease and vaccination could be observed.

The TMR report drawing from the same and other insightful factors has segregated the global cholera vaccines market based on type, distribution channel, and geography. In terms of type, the cholera vaccines market is bifurcated into monovalent and bivalent vaccines. On the basis of distribution channel, the cholera vaccines market is split into hospital pharmacies, retail pharmacies, and online pharmacies.

In accordance with regional perspective, the global cholera vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Cholera is more prevalent in developing regions such as Asia Pacific, Latin America, etc. This is expected to fuel the market in the regions during the forecast period. The cholera vaccine market in North America and Europe is expected to expand at a slow pace due to the fact that the U.S. and European countries have good sanitation systems and clean water.

Prominent players operating in the global cholera vaccine market are profiled in this report to give a better competitive analysis and these include Valneva SE, PaxVax, Inc., EuBiologics, Co. Ltd., and Sanofi.

Request a free brochure report here - http://bit.ly/2ICsoYA

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]